Allon Therapeutics plunges 95% after trial failure
The Canadian company, which specializes in treatments for degenerative brain diseases, was founded on the basis of research by Prof. Illana Gozes of TAU.
By GALI WEINREB/GLOBESbrain(photo credit: Wikicommons)
if(catID != 151){
var cont = `Take Israel home with the new Jerusalem Post Store
